Literature DB >> 25103354

Letter: telmisartan associated enteropathy - is there any class effect? Authors' reply.

G Cammarota1, G Ianiro, S Bibbò, A Gasbarrini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25103354     DOI： 10.1111/apt.12870

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN： 0269-2813            Impact factor:   8.171


× No keyword cloud information.
  6 in total

Review 1.  Association of sprue-like enteropathy and angiotensin receptor-1 antagonists.

Authors:  René R Wenzel; Christian Datz
Journal:  Wien Klin Wochenschr       Date:  2019-08-30       Impact factor: 1.704

2.  Telmisartan-induced sprue-like enteropathy: a case report.

Authors:  Natalia Alzueta; Amaya Echeverría; Lorea Sanz; Carmen Fontela; Teresa Acín; Lidia Montenegro; Javier Garjón
Journal:  Eur J Hosp Pharm       Date:  2018-09-25

Review 3.  Angiotensin II receptor blockers and gastrointestinal adverse events of resembling sprue-like enteropathy: a systematic review.

Authors:  Ayesha Kamal; Christopher Fain; Angela Park; Peiqi Wang; Eduardo Gonzalez-Velez; Daniel A Leffler; Susan M Hutfless
Journal:  Gastroenterol Rep (Oxf)       Date:  2019-06-01

4.  Clinical-Pathological Conference Series from the Medical University of Graz: Case No 156: 82-year-old woman with chronic diarrhea and weight loss of 20 kilograms.

Authors:  Elisabeth Fabian; Dietmar Schiller; Heimo Wenzl; Carolin Lackner; Josef Donnerer; Alexander Ziachehabi; Rene Silye; Rainer Schöfl; Guenter J Krejs
Journal:  Wien Klin Wochenschr       Date:  2015-11-26       Impact factor: 1.704

5.  Telmisartan-induced sprue-like enteropathy: a case report and a review of patients using non-olmesartan angiotensin receptor blockers.

Authors:  Harshal Surendra Mandavdhare; Vishal Sharma; Kaushal K Prasad; Amit Kumar; Manish Rathi; Surinder S Rana
Journal:  Intest Res       Date:  2017-06-12

6.  Severe intestinal malabsorption associated with ACE inhibitor or angiotensin receptor blocker treatment. An observational cohort study in Germany and Italy.

Authors:  Peter Malfertheiner; Claudio Ripellino; Nazarena Cataldo
Journal:  Pharmacoepidemiol Drug Saf       Date:  2018-02-19       Impact factor: 2.890
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.